BHC Earnings & Financial Statements
Bausch Health Companies Inc.
$6.04
$0.00(0.00%)
64
Overall
60
Value
80
Tech
52
Quality
Market Cap
$2.26B
Volume
1.03M
52W Range
$4.33 - $8.00
Target Price
$7.58
BHC earnings and financial statements: Bausch Health Companies Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
BHC Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $10.27B | $9.63B | $8.76B | $8.12B | $8.43B |
| Cost of revenue | $3.01B | $2.78B | $2.56B | $2.36B | $2.39B |
| Operating income | $1.81B | $1.55B | $963.00M | $454.00M | $450.00M |
| EBITDA | $3.27B | $2.88B | $2.27B | $2.83B | $2.00B |
| Net income | $157.00M | -$46.00M | -$592.00M | -$225.00M | -$948.00M |
| EPS (diluted) | $0.42 | $-0.13 | $-1.62 | $-0.62 | $-2.64 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $26.37B | $26.52B | $27.35B | $25.69B | $29.20B |
| Total liabilities | $25.99B | $26.84B | $27.43B | $25.43B | $29.24B |
| Shareholders’ equity | -$554.00M | -$1.28B | -$1.02B | -$692.00M | -$106.00M |
| Cash and equivalents | $1.31B | $1.18B | $947.00M | $564.00M | $582.00M |
| Long-term debt | $20.59B | $18.94B | $21.94B | $20.33B | $22.65B |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $1.40B | $1.60B | $1.03B | -$728.00M | $1.43B |
| Capital expenditure | -$407.00M | -$340.00M | -$272.00M | -$268.00M | -$283.00M |
| Free cash flow | $993.00M | $1.26B | $760.00M | -$996.00M | $1.14B |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BHC | $6.04 | 0% | 1.03M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Bausch Health Companies Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW